Bispecific Antibodies in Myeloma

In this episode, we delve into the latest data on bispecific antibodies in multiple myeloma with Dr. Ajai Chari. Here are the key studies discussed:
1. Teclistamab (MajesTEC-1 trial): pubmed.ncbi.nl...
2. Correlative analysis from MajesTEC-1 trial: ashpublication...
3. Talquetamab (MonumenTAL-1 trial): pubmed.ncbi.nl...
4. Phase 1 trial of fixed-duration cevostamab:
ashpublication...
5. Phase 1 trial of ABBV-383: pubmed.ncbi.nl...
6. Paper summarizing infections with different bispecific antibodies in myeloma: pubmed.ncbi.nl...